286 related articles for article (PubMed ID: 28795410)
41. 'Agranular CD4+ CD56+ hematodermic neoplasm' (blastic NK-cell lymphoma) originates from a population of CD56+ precursor cells related to plasmacytoid monocytes.
Petrella T; Comeau MR; Maynadié M; Couillault G; De Muret A; Maliszewski CR; Dalac S; Durlach A; Galibert L
Am J Surg Pathol; 2002 Jul; 26(7):852-62. PubMed ID: 12131152
[TBL] [Abstract][Full Text] [Related]
42. Flow Cytometry Identifies a Spectrum of Maturation in Myeloid Neoplasms Having Plasmacytoid Dendritic Cell Differentiation.
Hamadeh F; Awadallah A; Meyerson HJ; Beck RC
Cytometry B Clin Cytom; 2020 Jan; 98(1):43-51. PubMed ID: 30614203
[TBL] [Abstract][Full Text] [Related]
43. Blastic plasmacytoid dendritic cell neoplasm : report of two cases.
Tsunoda K; Satoh T; Akasaka K; Ishikawa Y; Ishida Y; Masuda T; Akasaka T
J Clin Exp Hematop; 2012; 52(1):23-9. PubMed ID: 22706527
[TBL] [Abstract][Full Text] [Related]
44. Blastic plasmacytoid dendritic-cell neoplasia: a challenging case report.
Koerber RM; Held SAE; Vonnahme M; Feldmann G; Wenzel J; Gütgemann I; Brossart P; Heine A
J Cancer Res Clin Oncol; 2022 Mar; 148(3):743-748. PubMed ID: 34529129
[TBL] [Abstract][Full Text] [Related]
45. Clinical Characteristics and Diagnosis of Acute Myeloid Leukemia with CD56-Blastic Plasmacytoid Dendritic Cell Neoplasm.
Zhang X; Wu Y; Li C; Shen K; Li R
Clin Lab; 2023 Jun; 69(6):. PubMed ID: 37307129
[TBL] [Abstract][Full Text] [Related]
46. Characterization of CD56+ dendritic-like cells: a normal counterpart of blastic plasmacytoid dendritic cell neoplasm?
Osaki Y; Yokohama A; Saito A; Tahara K; Yanagisawa K; Ogawa Y; Ishizaki T; Mitsui T; Koiso H; Takizawa M; Uchiumi H; Saitoh T; Handa H; Murakami H; Tsukamoto N; Nojima Y
PLoS One; 2013; 8(11):e81722. PubMed ID: 24312342
[TBL] [Abstract][Full Text] [Related]
47. [Clinical Features of Patients with Blastic Plasmacytoid Dendritic Cell Neoplasm].
Wu LZ; Yu Q; Jiang Y; Peng HL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Feb; 28(1):307-313. PubMed ID: 32027294
[TBL] [Abstract][Full Text] [Related]
48. Immunophenotypic analysis of myeloperoxidase-negative leukemia cutis and blastic plasmacytoid dendritic cell neoplasm.
Cronin DM; George TI; Reichard KK; Sundram UN
Am J Clin Pathol; 2012 Mar; 137(3):367-76. PubMed ID: 22338048
[TBL] [Abstract][Full Text] [Related]
49. Clinical and biologic features of CD4(+)CD56(+) malignancies.
Feuillard J; Jacob MC; Valensi F; Maynadié M; Gressin R; Chaperot L; Arnoulet C; Brignole-Baudouin F; Drénou B; Duchayne E; Falkenrodt A; Garand R; Homolle E; Husson B; Kuhlein E; Le Calvez G; Sainty D; Sotto MF; Trimoreau F; Béné MC
Blood; 2002 Mar; 99(5):1556-63. PubMed ID: 11861268
[TBL] [Abstract][Full Text] [Related]
50. Molecular Features of Blastic Plasmacytoid Dendritic Cell Neoplasm: DNA Mutations and Epigenetics.
Sapienza MR; Pileri S
Hematol Oncol Clin North Am; 2020 Jun; 34(3):511-521. PubMed ID: 32336416
[TBL] [Abstract][Full Text] [Related]
51. Immunophenotypic characterization of reactive and neoplastic plasmacytoid dendritic cells permits establishment of a 10-color flow cytometric panel for initial workup and residual disease evaluation of blastic plasmacytoid dendritic cell neoplasm.
Wang W; Khoury JD; Miranda RN; Jorgensen JL; Xu J; Loghavi S; Li S; Pemmaraju N; Nguyen T; Medeiros LJ; Wang SA
Haematologica; 2021 Apr; 106(4):1047-1055. PubMed ID: 32241840
[TBL] [Abstract][Full Text] [Related]
52. CD4-Negative Variant of Cutaneous Blastic Plasmacytoid Dendritic Cell Neoplasm With a Novel PBRM1 Mutation in an 11-Year-Old Girl.
Yigit N; Suarez LF; Roth LG; Orazi A; Tam W
Am J Clin Pathol; 2017 May; 147(5):453-460. PubMed ID: 28419186
[TBL] [Abstract][Full Text] [Related]
53. Blastic plasmacytoid dendritic cell neoplasm: a single-center experience.
An HJ; Yoon DH; Kim S; Shin SJ; Huh J; Lee KH; Suh C
Ann Hematol; 2013 Mar; 92(3):351-6. PubMed ID: 23135479
[TBL] [Abstract][Full Text] [Related]
54. Blastic Plasmacytoid Dendritic Cell Neoplasia: A Single Center Experience.
Demiröz AS; Demirkesen C; Salihoğlu A; Tüzüner N
Turk J Haematol; 2020 Feb; 37(1):48-52. PubMed ID: 31752482
[TBL] [Abstract][Full Text] [Related]
55. Blastic plasmacytoid dendritic cell neoplasm: evolving insights in an aggressive hematopoietic malignancy with a predilection of skin involvement.
Gera S; Dekmezian MS; Duvic M; Tschen JA; Vega F; Cho-Vega JH
Am J Dermatopathol; 2014 Mar; 36(3):244-51. PubMed ID: 24247574
[TBL] [Abstract][Full Text] [Related]
56. E-Cadherin Expression and Blunted Interferon Response in Blastic Plasmacytoid Dendritic Cell Neoplasm.
Lorenzi L; Lonardi S; Vairo D; Bernardelli A; Tomaselli M; Bugatti M; Licini S; Arisi M; Cerroni L; Tucci A; Vermi W; Giliani SC; Facchetti F
Am J Surg Pathol; 2021 Oct; 45(10):1428-1438. PubMed ID: 34081040
[TBL] [Abstract][Full Text] [Related]
57. Blastic plasmacytoid dendritic cell neoplasm (BPDCN): A promising future in the era of targeted therapeutics.
Adimora IJ; Wilson NR; Pemmaraju N
Cancer; 2022 Aug; 128(16):3019-3026. PubMed ID: 35726525
[TBL] [Abstract][Full Text] [Related]
58. Novel Therapeutic Approaches in Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): Era of Targeted Therapy.
Wilson NR; Konopleva M; Khoury JD; Pemmaraju N
Clin Lymphoma Myeloma Leuk; 2021 Nov; 21(11):734-740. PubMed ID: 34226167
[TBL] [Abstract][Full Text] [Related]
59. Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation, lacking cutaneous involvement: Case series and literature review.
Rauh MJ; Rahman F; Good D; Silverman J; Brennan MK; Dimov N; Liesveld J; Ryan DH; Burack WR; Bennett JM
Leuk Res; 2012 Jan; 36(1):81-6. PubMed ID: 21890199
[TBL] [Abstract][Full Text] [Related]
60. Spontaneous regression of cutaneous blastic plasmacytoid dendritic cell neoplasm followed by acute monocytic leukemia evolving from myelodysplastic syndrome.
Yasuda H; Takaku T; Tomomatsu J; Hosone M; Tanaka H; Komatsu N
Intern Med; 2014; 53(23):2717-20. PubMed ID: 25447656
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
